Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations
about
Variation in LPA is associated with Lp(a) levels in three populations from the Third National Health and Nutrition Examination SurveyA genome-wide association study identifies protein quantitative trait loci (pQTLs)The low density lipoprotein receptor is not required for normal catabolism of Lp(a) in humansInsulin sensitivity and Lp(alpha) concentrations in normoglycemic offspring of type 2 diabetic parentsSilent coronary artery disease in type 2 diabetes mellitus: the role of Lipoprotein(a), homocysteine and apo(a) polymorphismLipoprotein abnormalities in South Asians and its association with cardiovascular disease: Current state and future directionsHuman Genetics and the Causal Role of Lipoprotein(a) for Various DiseasesEarly renal failure as a cardiovascular disease: Focus on lipoprotein(a) and prothrombotic stateLPA gene: interaction between the apolipoprotein(a) size ('kringle IV' repeat) polymorphism and a pentanucleotide repeat polymorphism influences Lp(a) lipoprotein levelApolipoprotein[a] secretion from hepatoma cells is regulated in a size-dependent manner by alterations in disulfide bond formationLipoprotein(a) catabolism is regulated by proprotein convertase subtilisin/kexin type 9 through the low density lipoprotein receptorLipoprotein (a)-We Know So Much Yet Still Have Much to Learn …Genetics of the Lp(a)/apo(a) system in an autochthonous Black African population from the GabonThe number of identical kringle IV repeats in apolipoprotein(a) affects its processing and secretion by HepG2 cellsRelation of Apo(a) size to carotid atherosclerosis in an elderly multiethnic populationMonogenic dyslipidemias: window on determinants of plasma lipoprotein metabolismEmerging Affinity-Based Proteomic Technologies for Large-Scale Plasma Profiling in Cardiovascular Disease.Genome-wide association study of plasma lipoprotein(a) levels identifies multiple genes on chromosome 6qGenetic variation in LPAL2, LPA, and PLG predicts plasma lipoprotein(a) level and carotid artery disease risk.Higher Lipoprotein (a) Levels Are Associated with Better Pulmonary Function in Community-Dwelling Older People - Data from the Berlin Aging Study II.Relationship of lipoprotein(a) to variables of coagulation in hypertensive subjects.Effect of diet-induced weight loss on lipoprotein(a) levels in obese individuals with and without type 2 diabetesSingle-nucleotide polymorphisms in LPA explain most of the ancestry-specific variation in Lp(a) levels in African Americans.LPA and PLG sequence variation and kringle IV-2 copy number in two populations.Significant associations between lipoprotein(a) and corrected apolipoprotein B-100 levels in African-Americans.Sequence polymorphisms in the apolipoprotein (a) gene. Evidence for dissociation between apolipoprotein(a) size and plasma lipoprotein(a) levels.Lipoprotein (a) and strokeLipoprotein (a): structure, pathophysiology and clinical implications.Association of Lp-PLA(2) activity with allele-specific Lp(a) levels in a bi-ethnic population.Comparative analysis of the apo(a) gene, apo(a) glycoprotein, and plasma concentrations of Lp(a) in three ethnic groups. Evidence for no common "null" allele at the apo(a) locus.The inverse association of plasma lipoprotein(a) concentrations with apolipoprotein(a) isoform size is not due to differences in Lp(a) catabolism but to differences in production rateGenetics of coronary heart disease with reference to ApoAI-CIII-AIV gene region.Changes in lipoprotein(a), oxidized phospholipids, and LDL subclasses with a low-fat high-carbohydrate dietGenetic variants in PLG, LPA, and SIGLEC 14 as well as smoking contribute to plasma plasminogen levels.Copy number variation of the Lipoprotein(a) (LPA) gene is associated with coronary artery disease in a southern Han Chinese populationHormonal influences on lipoprotein(a) metabolism.Growth hormone deficiency and vascular risk.Evolving targets for lipid-modifying therapyLipoprotein(a) levels, apo(a) isoform size, and coronary heart disease risk in the Framingham Offspring Study.Dyslipidaemia in rheumatological autoimmune diseases
P2860
Q21135561-4DCFDF26-F4AA-4B3B-ADA7-BEBC0F302571Q21145048-8C2F57D8-6B8C-460B-99EA-7260242F2464Q24562140-14DA9993-B7B3-42BB-A897-40B7E52BD8B9Q24796609-BBB3B169-EA44-46DA-8F4D-59D75693AFCDQ24800332-29762B0F-E2E3-4581-BD87-AE680859B3B7Q26750131-B01C1D7B-8CC6-4C5B-954E-2ADD116D0523Q28079294-DD29C0CC-EFAF-4DA3-B4A5-2040A3CFEA92Q28081493-BD527623-ECEA-481E-A67A-53D1F472D4C7Q28144616-EC386834-61CD-4F2E-BA5F-44A551D16D88Q28206647-D93B55FE-975A-4E03-AD79-505A6BB3748CQ28258969-2C0F7751-EC82-4D69-A8AE-A15A1E503FB0Q28275137-5EEE7979-E9B2-4DDC-93D1-564CFD4525AEQ28280178-7179A960-8D21-44AB-8D75-5894318E2234Q28298392-8893FFD1-F20C-4DB8-BBEE-4530C7134329Q28344927-9769708A-16D4-4D4E-8CE1-D3BFB950A2C8Q28363810-8EF86706-2FFF-4C24-BEBA-92A1DDF5BE14Q30234679-A9575367-954E-42EA-809E-AE4CDFF806F6Q30486850-F1C10441-8FF6-4676-8716-89E29E9E9C7FQ30497894-C861EE14-7962-429A-B3C5-22D6AE92391DQ30999453-FBA5CCAD-74D2-4A41-929B-993D2E85B397Q32056571-87BD0CAD-ED6F-46C4-90FF-5C4AA4099D85Q33654017-699B8B28-6070-4600-869E-7366C97FE525Q33808934-20DDFDF0-4636-43F5-89E5-B0D9C4C0E309Q33818108-01A7809A-9824-487B-B160-386B7986A0E7Q33892999-76C7C700-2FBF-4D6F-B7C5-0CB94A4B43E4Q33896318-0D9AB7E6-26B5-44F5-A500-F2C89814E710Q34015050-EEEB9608-E16E-4ED8-A2D9-BCA037C3F527Q34020677-20CFAF07-5F52-49C5-927F-AEEE1AA09DDBQ34037051-6AF27F9D-09E2-4EC1-AFE0-23280AAB41FCQ34151817-2D90C033-FBA6-42BB-8C92-00BE94D32129Q34154477-4087B329-CBFB-4DA1-B70B-C14D61188799Q34179026-9A8993B2-0A3D-4EBB-B179-BC91B76328A5Q34188087-18955929-23A6-4D02-AEEA-4BC968148A3AQ34508365-6E0DEE34-6EEA-4477-87FC-749F4BB8B58BQ34547826-737102A6-88C2-452B-B56C-9D7F8EED4F93Q34669332-A0AA3209-3933-457F-ADD6-B9D950D28798Q34722657-337C9048-83CC-47CA-938D-1AA04434D33EQ34880292-C5B14F57-B3FB-45FC-BA9A-BBAAF09C6D2AQ34955900-C544A8D7-2B54-4A07-B2BE-A3D04CA30361Q35029916-D08245F7-A56F-4B3F-8AE9-D7C08E7DBC5E
P2860
Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Apolipoprotein(a) gene account ...... lipoprotein(a) concentrations
@ast
Apolipoprotein(a) gene account ...... lipoprotein(a) concentrations
@en
type
label
Apolipoprotein(a) gene account ...... lipoprotein(a) concentrations
@ast
Apolipoprotein(a) gene account ...... lipoprotein(a) concentrations
@en
prefLabel
Apolipoprotein(a) gene account ...... lipoprotein(a) concentrations
@ast
Apolipoprotein(a) gene account ...... lipoprotein(a) concentrations
@en
P2093
P2860
P356
P1476
Apolipoprotein(a) gene account ...... lipoprotein(a) concentrations
@en
P2093
P2860
P356
10.1172/JCI115855
P407
P577
1992-07-01T00:00:00Z